PMID- 25127375 OWN - NLM STAT- MEDLINE DCOM- 20150610 LR - 20211021 IS - 1944-9917 (Electronic) IS - 0888-8809 (Print) IS - 0888-8809 (Linking) VI - 28 IP - 10 DP - 2014 Oct TI - Lipocalin 2 is a regulator of macrophage polarization and NF-kappaB/STAT3 pathway activation. PG - 1616-28 LID - 10.1210/me.2014-1092 [doi] AB - Lipocalin 2 (Lcn2) has been previously characterized as an adipokine/cytokine and implicated in obesity and inflammation. Herein, we investigated the role and potential mechanism of Lcn2 in the regulation of macrophage polarization in obesity-associated inflammation. We observed that Lcn2-/- mice displayed an up-regulation of expression of M1 macrophage marker Cd11c but a down-regulation of M2 marker arginase 1 in adipose tissue and liver of mice upon a high-fat diet feeding. Lcn2-deficient bone marrow-derived macrophages (BMDMs) were more sensitive to lipopolysaccharide (LPS) stimulation, leading to a more profound up-regulation of expression of pro-inflammatory markers than wild-type (WT) BMDMs. Accordingly, LPS stimulation elicited an increase in the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB), c-Jun, and STAT3 signaling pathways as well as an up-regualtion of expression of NF-kappaB and STAT3 target genes such as IL-1beta, IL-6, iNOS, and MCP-1 in Lcn2-/- BMDMs compared with WT controls. Pre-treatment of recombinant Lcn2 attenuated LPS-stimulated degradation of IkappaBalpha and STAT3 phosphorylation as well as LPS-induced gene expression of IL-6 and iNOS in Lcn2-/- BMDMs. Moreover, the NFkappaB inhibitor markedly blocked LPS-stimulated STAT3 phosphorylation in Lcn2-/- BMDMs. These results together with the time course of Lcn2 secretion, NFkappaB and STAT3 phosphorylation in response to LPS stimulation, suggest that Lcn2 plays a role as an anti-inflammatory regulator in macrophage activation via modulating a feed-forward activation of NFkappaB-STAT3 loop. FAU - Guo, Hong AU - Guo H AD - Department of Food Science and Nutrition, University of Minnesota-Twin Cities, Saint Paul, Minnesota 55108. FAU - Jin, Daozhong AU - Jin D FAU - Chen, Xiaoli AU - Chen X LA - eng GR - P30 DK050456/DK/NIDDK NIH HHS/United States GR - R01 DK080743/DK/NIDDK NIH HHS/United States GR - R01DK080743/DK/NIDDK NIH HHS/United States GR - 2P30DK050456/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20140815 PL - United States TA - Mol Endocrinol JT - Molecular endocrinology (Baltimore, Md.) JID - 8801431 RN - 0 (Acute-Phase Proteins) RN - 0 (CD11c Antigen) RN - 0 (Lipocalin-2) RN - 0 (Lipocalins) RN - 0 (NF-kappa B) RN - 0 (Oncogene Proteins) RN - 0 (STAT3 Transcription Factor) RN - 126469-30-5 (Lcn2 protein, mouse) RN - EC 3.5.3.1 (Arg1 protein, mouse) RN - EC 3.5.3.1 (Arginase) SB - IM MH - Acute-Phase Proteins/genetics/*metabolism MH - Adipose Tissue/metabolism MH - Animals MH - Arginase/metabolism MH - CD11c Antigen/metabolism MH - Cell Polarity/*physiology MH - Diet, High-Fat MH - Inflammation/metabolism MH - Lipocalin-2 MH - Lipocalins/genetics/*metabolism MH - Liver/metabolism MH - Macrophages/*metabolism MH - Mice MH - Mice, Knockout MH - NF-kappa B/*metabolism MH - Obesity/metabolism MH - Oncogene Proteins/genetics/*metabolism MH - Phosphorylation MH - STAT3 Transcription Factor/*metabolism MH - Signal Transduction/*physiology PMC - PMC4179633 EDAT- 2014/08/16 06:00 MHDA- 2015/06/11 06:00 PMCR- 2015/10/01 CRDT- 2014/08/16 06:00 PHST- 2014/08/16 06:00 [entrez] PHST- 2014/08/16 06:00 [pubmed] PHST- 2015/06/11 06:00 [medline] PHST- 2015/10/01 00:00 [pmc-release] AID - ME-14-1092 [pii] AID - 10.1210/me.2014-1092 [doi] PST - ppublish SO - Mol Endocrinol. 2014 Oct;28(10):1616-28. doi: 10.1210/me.2014-1092. Epub 2014 Aug 15.